With a new reasoning model that matches the performance of ChatGPT o1, DeepSeek managed to turn restrictions into innovation. What will really matter in the long run? That’s the question we tackle ...
US FDA grants fast track designation to Clarity Pharma’s Cu-64 SAR-bisPSMA in biochemical recurrence of prostate cancer: Sydney, Australia Monday, January 27, 2025, 14:00 Hrs [I ...